EXI1:F:F-iShares SLI UCITS ETF (DE) (EUR)

ETF | Others |

Last Closing

USD 152

Change

+1.84 (+1.23)%

Market Cap

N/A

Volume

N/A

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-03-18 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
SXR8:F iShares Core S&P 500 UCITS ETF..

-6.54 (-1.18%)

USD 108.00B
UIM5:F UBS (Lux) Fund Solutions - MSC..

-0.42 (-0.81%)

USD 105.67B
ZPDJ:F SPDR® MSCI Japan UCITS ETF

-0.46 (-0.80%)

USD 104.83B
XDNY:F Xtrackers MSCI Japan ESG Scree..

-0.11 (-0.72%)

USD 62.86B
VUSA:F Vanguard Funds Public Limited ..

-1.62 (-1.63%)

USD 51.63B
SXRZ:F iShares VII PLC - iShares Nikk..

-2.00 (-0.85%)

USD 49.04B
XJSE:F Xtrackers II - Japan Governmen..

-0.02 (-0.24%)

USD 41.48B
0ZC:F Zscaler Inc

-3.56 (-1.91%)

USD 37.92B
BSND:F Danone SA

-0.30 (-2.13%)

USD 33.83B
VGWL:F Vanguard FTSE All-World UCITS ..

-0.40 (-0.32%)

USD 24.77B

ETFs Containing EXI1:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 8.40% 80% B- 72% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 8.40% 79% B- 72% C
Trailing 12 Months  
Capital Gain 11.88% 75% C 65% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 11.88% 72% C 57% F
Trailing 5 Years  
Capital Gain 86.14% 56% F 57% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 86.14% 56% F 41% F
Average Annual (5 Year Horizon)  
Capital Gain 10.14% 68% D+ 64% D
Dividend Return 10.14% 65% D 56% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 12.25% 56% F 86% B+
Risk Adjusted Return 82.83% 81% B- 86% B+
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike